Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,133 | -8,566 | -9,384 | -15,612 | -11,284 |
| Depreciation Amortization | 762 | 495 | 251 | 1,767 | 1,151 |
| Accounts receivable | 249 | 87 | 80 | 592 | -534 |
| Other Working Capital | -2,300 | -1,919 | -115 | 118 | -1,157 |
| Other Operating Activity | 1,273 | 1,639 | 5,702 | -842 | 203 |
| Operating Cash Flow | $-11,149 | $-8,264 | $-3,466 | $-13,977 | $-11,621 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,002 | -5,002 | N/A | N/A | 0 |
| PPE Investments | 37 | 32 | 30 | 848 | 851 |
| Net Acquisitions | 569 | 569 | 285 | 569 | 285 |
| Investing Cash Flow | $-4,396 | $-4,401 | $315 | $1,417 | $1,136 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,009 | 6,002 | 6,002 | 5,007 | 5,007 |
| Other Financing Activity | -497 | -497 | -497 | -488 | -488 |
| Financing Cash Flow | $5,512 | $5,505 | $5,505 | $4,519 | $4,519 |
| Beginning Cash Position | 20,644 | 20,644 | 20,644 | 28,685 | 28,685 |
| End Cash Position | 10,611 | 13,484 | 22,998 | 20,644 | 22,719 |
| Net Cash Flow | $-10,033 | $-7,160 | $2,354 | $-8,041 | $-5,966 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,149 | -8,264 | -3,466 | -13,977 | -11,621 |
| Capital Expenditure | -5 | -5 | N/A | -72 | -46 |
| Free Cash Flow | -11,154 | -8,269 | -3,466 | -14,049 | -11,667 |